Smith & Nephew SNATS - 20 Year Stock Price History | SNN
Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits. The latest closing stock price for Smith & Nephew SNATS as of November 12, 2019 is 42.26.
- The all-time high Smith & Nephew SNATS stock closing price was 48.59 on September 26, 2019.
- The Smith & Nephew SNATS 52-week high stock price is 48.93, which is 15.8% above the current share price.
- The Smith & Nephew SNATS 52-week low stock price is 35.39, which is 16.3% below the current share price.
- The average Smith & Nephew SNATS stock price for the last 52 weeks is 41.74.
| Smith & Nephew SNATS Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 42.3981 | 36.4000 | 48.5900 | 35.5100 | 42.2600 | 13.06% |
| 2018 | 36.3446 | 34.9000 | 39.4400 | 32.4000 | 37.3800 | 6.77% |
| 2017 | 34.1090 | 29.9900 | 38.5000 | 29.9000 | 35.0100 | 16.39% |
| 2016 | 32.3880 | 34.8000 | 35.0600 | 27.1100 | 30.0800 | -15.51% |
| 2015 | 35.0108 | 35.9500 | 37.7800 | 32.4800 | 35.6000 | -3.10% |
| 2014 | 32.9098 | 28.3360 | 38.9080 | 28.3360 | 36.7400 | 28.03% |
| 2013 | 24.0164 | 22.2920 | 28.7400 | 21.1600 | 28.6960 | 29.49% |
| 2012 | 20.3023 | 19.5560 | 22.4640 | 18.0520 | 22.1600 | 15.06% |
| 2011 | 20.5597 | 21.0400 | 24.0760 | 16.8680 | 19.2600 | -8.37% |
| 2010 | 19.1278 | 20.6520 | 21.5760 | 16.5160 | 21.0200 | 2.54% |
| 2009 | 15.8762 | 13.0400 | 20.5520 | 12.2280 | 20.5000 | 58.67% |
| 2008 | 21.6752 | 23.0520 | 27.4280 | 12.1560 | 12.9200 | -43.75% |
| 2007 | 24.1161 | 20.9480 | 27.1080 | 20.8280 | 22.9680 | 9.73% |
| 2006 | 17.8203 | 18.9440 | 21.0600 | 14.7800 | 20.9320 | 12.90% |
| 2005 | 19.1965 | 20.3320 | 21.1320 | 16.1040 | 18.5400 | -10.45% |
| 2004 | 19.6518 | 16.7360 | 23.2000 | 16.3200 | 20.7040 | 23.47% |
| 2003 | 13.2164 | 12.3720 | 16.9200 | 10.7200 | 16.7680 | 36.55% |
| 2002 | 11.5938 | 12.0600 | 12.7820 | 9.6800 | 12.2800 | 0.99% |
| 2001 | 9.9700 | 9.2000 | 12.1800 | 8.3700 | 12.1600 | 31.83% |
| 2000 | 7.9306 | 8.2180 | 9.2240 | 6.1403 | 9.2240 | 12.01% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.588B | $4.904B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $148.090B | 27.01 |
| Medtronic (MDT) | Ireland | $143.599B | 20.16 |
| Stryker (SYK) | United States | $74.738B | 25.13 |
| Boston Scientific (BSX) | United States | $56.464B | 26.65 |
| Baxter (BAX) | United States | $40.084B | 24.31 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $32.664B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $29.619B | 18.58 |
| Terumo (TRUMY) | Japan | $27.722B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.691B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.121B | 0.00 |
| ResMed (RMD) | United States | $20.684B | 38.16 |
| Sunny Optical Technology (SNPTF) | China | $18.592B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.550B | 50.64 |
| Insulet (PODD) | United States | $10.476B | 498.41 |
| Canopy Growth (CGC) | Canada | $7.475B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.947B | 20.47 |
| Perrigo (PRGO) | Ireland | $6.812B | 12.70 |
| William Demant Holdings (WILYY) | Denmark | $6.665B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.420B | 0.00 |
| Haemonetics (HAE) | United States | $6.037B | 40.79 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.155B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $3.920B | 0.00 |
| NuVasive (NUVA) | United States | $3.757B | 29.59 |
| ICU Medical (ICUI) | United States | $3.456B | 22.41 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.380B | 0.00 |
| Neogen (NEOG) | United States | $3.369B | 56.38 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.987B | 0.00 |
| Quidel (QDEL) | United States | $2.480B | 23.54 |
| National Vision Holdings (EYE) | United States | $2.179B | 49.55 |
| Agios Pharmaceuticals (AGIO) | United States | $1.976B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.570B | 0.00 |
| InMode (INMD) | Israel | $1.293B | 0.00 |
| Aphria (APHA) | $1.275B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.245B | 28.70 |
| AtriCure (ATRC) | United States | $1.109B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.936B | 17.53 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.863B | 22.01 |
| Lantheus Holdings (LNTH) | United States | $0.842B | 21.04 |
| NanoString Technologies (NSTG) | United States | $0.826B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.775B | 0.00 |
| Omeros (OMER) | United States | $0.669B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.662B | 37.49 |
| PetIQ (PETQ) | United States | $0.655B | 16.01 |
| HEXO (HEXO) | $0.604B | 0.00 | |
| Quanterix (QTRX) | United States | $0.589B | 0.00 |
| Cerus (CERS) | United States | $0.577B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.572B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.529B | 31.74 |
| Surmodics (SRDX) | United States | $0.527B | 54.97 |
| Owens & Minor (OMI) | United States | $0.454B | 16.79 |
| MacroGenics (MGNX) | United States | $0.404B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.383B | 27.79 |
| BioLife Solutions (BLFS) | United States | $0.341B | 104.75 |
| Meridian Bioscience (VIVO) | United States | $0.337B | 11.62 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.328B | 0.00 |
| Zynex (ZYXI) | United States | $0.295B | 33.33 |
| Viemed Healthcare (VMD) | United States | $0.266B | 0.00 |
| Bovie Medical (APYX) | United States | $0.238B | 0.00 |
| United Health Products (UEEC) | United States | $0.185B | 0.00 |
| Vapotherm (VAPO) | United States | $0.183B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.172B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.149B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.142B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.133B | 0.00 |
| Female Health (VERU) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.126B | 8.87 |
| Rockwell Medical (RMTI) | United States | $0.118B | 0.00 |
| Chimerix (CMRX) | United States | $0.101B | 0.00 |
| United-Guardian (UG) | United States | $0.085B | 21.62 |
| Chembio Diagnostics (CEMI) | United States | $0.080B | 0.00 |
| Nephros (NEPH) | United States | $0.072B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.053B | 0.00 |
| Surface Oncology (SURF) | United States | $0.048B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.046B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.023B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.020B | 0.00 |
| Senestech (SNES) | United States | $0.019B | 0.00 |
| Myomo (MYO) | United States | $0.012B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.011B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.011B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.008B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
